Magnusiomyces Capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Structured Review of the Literature. [PDF]
Gómez-Hernández C +9 more
europepmc +1 more source
Outcomes of patients with <i>Candidozyma auris</i> vs. <i>Candida glabrata</i> and <i>C. krusei</i>: the after-effect of lifetime contact precautions. [PDF]
Kewalramani A +7 more
europepmc +1 more source
Global surveillance of <i>Candida albicans</i>: MIC distributions, resistance patterns, and temporal trends from the Antimicrobial Testing Leadership and Surveillance program (2015-2024). [PDF]
Cai G, Zhang Z.
europepmc +1 more source
Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children. [PDF]
Colombo AL +7 more
europepmc +1 more source
The novel second-generation triterpenoid SCY-247 maintains <i>in vitro</i> and <i>in vivo</i> activity against resistant <i>Candida glabrata</i>. [PDF]
Wiederhold NP +5 more
europepmc +1 more source
Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases. [PDF]
Chen J +6 more
europepmc +1 more source
Updated Genomic Epidemiologic Description of Candida (Candidozyma) auris, United States. [PDF]
Parnell LA +8 more
europepmc +1 more source
Correction: Adaptive morphological changes link to poor clinical outcomes by conferring echinocandin tolerance in Candida tropicalis. [PDF]
Wu Y +9 more
europepmc +1 more source
Hospital-acquired <i>Candidozyma auris</i> infections as an emerging threat in Saudi Arabia and Egypt: A narrative review on epidemiology and prevention strategies. [PDF]
Amir OA +5 more
europepmc +1 more source

